Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

2 terminated/withdrawn out of 156 trials

Success Rate

92.0%

+5.4% vs industry average

Late-Stage Pipeline

13%

20 trials in Phase 3/4

Results Transparency

0 of 23 completed trials have results

Key Signals

51 recruiting

Enrollment Performance

Analytics

N/A

49(41.5%)

Phase 2

21(17.8%)

Phase 1

19(16.1%)

Phase 3

11(9.3%)

Phase 4

9(7.6%)

Early Phase 1

9(7.6%)

118Total

N/A(49)

Phase 2(21)

Phase 1(19)

Phase 3(11)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (156)

Showing 20 of 156 trials

NCT06088472Phase 1Active Not Recruiting

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Role: collaborator

NCT07301372Phase 2Completed

Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT07163299Phase 1Enrolling By Invitation

Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Role: collaborator

NCT05965687Phase 3Completed

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Role: collaborator

NCT06577792Not ApplicableActive Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Role: collaborator

NCT07295366Phase 4Completed

Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial

Role: lead

NCT07680933Phase 2Recruiting

Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)

Role: lead

NCT07634861Not ApplicableRecruiting

Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study)

Role: collaborator

NCT06711016Not ApplicableRecruiting

Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Role: collaborator

NCT07410377Early Phase 1Withdrawn

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Role: lead

NCT05129904Active Not Recruiting

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Role: collaborator

NCT07602439Active Not Recruiting

Early CMR in Acute MI

Role: lead

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT07332858Phase 1Recruiting

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Role: collaborator

NCT06241651Not ApplicableRecruiting

CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy

Role: collaborator

NCT06304779Not ApplicableRecruiting

The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Role: collaborator

NCT07546110Early Phase 1Not Yet Recruiting

An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).

Role: lead

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator